Eva S. Rodansky

965 total citations
13 papers, 643 citations indexed

About

Eva S. Rodansky is a scholar working on Genetics, Surgery and Oncology. According to data from OpenAlex, Eva S. Rodansky has authored 13 papers receiving a total of 643 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 4 papers in Surgery and 4 papers in Oncology. Recurrent topics in Eva S. Rodansky's work include Pancreatic and Hepatic Oncology Research (3 papers), Digestive system and related health (3 papers) and Inflammatory Bowel Disease (3 papers). Eva S. Rodansky is often cited by papers focused on Pancreatic and Hepatic Oncology Research (3 papers), Digestive system and related health (3 papers) and Inflammatory Bowel Disease (3 papers). Eva S. Rodansky collaborates with scholars based in United States. Eva S. Rodansky's co-authors include Peter Higgins, Laura A. Johnson, Scott D. Larsen, Richard R. Neubig, Jeffrey C. Horowitz, Andrew J. Haak, Kay Sauder, Jason R. Spence, Daniel J. Tschumperlin and Sha Huang and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Gastroenterology.

In The Last Decade

Eva S. Rodansky

13 papers receiving 638 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva S. Rodansky United States 9 233 167 151 138 108 13 643
Adam M. Zahm United States 13 401 1.7× 210 1.3× 188 1.2× 162 1.2× 102 0.9× 20 815
Christiane Arnold France 15 363 1.6× 183 1.1× 152 1.0× 228 1.7× 115 1.1× 20 919
Óscar Quintana-Bustamante Spain 15 472 2.0× 141 0.8× 226 1.5× 116 0.8× 78 0.7× 32 999
Amy E. Geddis United States 21 354 1.5× 160 1.0× 79 0.5× 85 0.6× 167 1.5× 42 1.1k
Françoise Créchet France 11 213 0.9× 62 0.4× 108 0.7× 152 1.1× 67 0.6× 20 703
Lasse Langholm Denmark 8 146 0.6× 71 0.4× 98 0.6× 80 0.6× 80 0.7× 16 571
Magdalena Potoczek United States 11 321 1.4× 84 0.5× 60 0.4× 162 1.2× 60 0.6× 16 589
Tingyan Shi China 16 371 1.6× 91 0.5× 184 1.2× 214 1.6× 72 0.7× 55 861
Regine Dahse Germany 17 353 1.5× 73 0.4× 225 1.5× 227 1.6× 81 0.8× 47 870
Yasuyuki Mizutani Japan 18 215 0.9× 138 0.8× 262 1.7× 356 2.6× 111 1.0× 90 863

Countries citing papers authored by Eva S. Rodansky

Since Specialization
Citations

This map shows the geographic impact of Eva S. Rodansky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva S. Rodansky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva S. Rodansky more than expected).

Fields of papers citing papers by Eva S. Rodansky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva S. Rodansky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva S. Rodansky. The network helps show where Eva S. Rodansky may publish in the future.

Co-authorship network of co-authors of Eva S. Rodansky

This figure shows the co-authorship network connecting the top 25 collaborators of Eva S. Rodansky. A scholar is included among the top collaborators of Eva S. Rodansky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva S. Rodansky. Eva S. Rodansky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Kumaraswamy, Anbarasu, Rahul Mannan, Eva S. Rodansky, et al.. (2025). LSD1+8a is an RNA biomarker of neuroendocrine prostate cancer. Neoplasia. 63. 101151–101151. 1 indexed citations
2.
Johnson, Laura A., Eva S. Rodansky, Kathryn A. Eaton, et al.. (2021). Effect of ABT-263 on Intestinal Fibrosis in Human Myofibroblasts, Human Intestinal Organoids, and the Mouse Salmonella typhimurium Model. Inflammatory Bowel Diseases. 28(2). 161–175. 10 indexed citations
3.
Steiner, Calen A., Eva S. Rodansky, Laura A. Johnson, et al.. (2020). AXL Is a Potential Target for the Treatment of Intestinal Fibrosis. Inflammatory Bowel Diseases. 27(3). 303–316. 36 indexed citations
4.
Johnson, Laura A., Eva S. Rodansky, David S. Moons, et al.. (2016). Optimisation of Intestinal Fibrosis and Survival in the MouseS. TyphimuriumModel for Anti-fibrotic Drug Discovery and Preclinical Applications. Journal of Crohn s and Colitis. 11(6). jjw210–jjw210. 6 indexed citations
5.
Xu, Guan, Laura A. Johnson, Jack Hu, et al.. (2015). Su2037 Detecting Bowel Wall Fibrosis With Photoacoustic Imaging in an Animal Model of Crohn's Disease. Gastroenterology. 148(4). S–581. 1 indexed citations
6.
Sisson, Thomas H., Iyabode O. Ajayi, Natalya Subbotina, et al.. (2015). Inhibition of Myocardin-Related Transcription Factor/Serum Response Factor Signaling Decreases Lung Fibrosis and Promotes Mesenchymal Cell Apoptosis. American Journal Of Pathology. 185(4). 969–986. 135 indexed citations
7.
Rodansky, Eva S., Laura A. Johnson, Sha Huang, Jason R. Spence, & Peter Higgins. (2015). Intestinal organoids: A model of intestinal fibrosis for evaluating anti-fibrotic drugs. Experimental and Molecular Pathology. 98(3). 346–351. 72 indexed citations
8.
Johnson, Laura A., Eva S. Rodansky, Kay Sauder, et al.. (2013). Matrix Stiffness Corresponding to Strictured Bowel Induces a Fibrogenic Response in Human Colonic Fibroblasts. Inflammatory Bowel Diseases. 19(5). 891–903. 133 indexed citations
9.
Johnson, Laura A., Eva S. Rodansky, Andrew J. Haak, et al.. (2013). Novel Rho/MRTF/SRF Inhibitors Block Matrix-stiffness and TGF-β–Induced Fibrogenesis in Human Colonic Myofibroblasts. Inflammatory Bowel Diseases. 20(1). 154–165. 163 indexed citations
10.
Rodansky, Eva S., et al.. (2012). ADAMTS13 promotes angiogenesis and modulates VEGF-induced angiogenesis. Microvascular Research. 84(2). 109–115. 38 indexed citations
11.
Johnson, Laura A., Kay Sauder, Eva S. Rodansky, Robert U. Simpson, & Peter Higgins. (2012). CARD-024, a vitamin D analog, attenuates the pro-fibrotic response to substrate stiffness in colonic myofibroblasts. Experimental and Molecular Pathology. 93(1). 91–98. 27 indexed citations
12.
Rodansky, Eva S., et al.. (2010). Inhibition of Endothelial Cell Tube Formation by ADAMTS13 Occurs Via Interaction with VEGF. Blood. 116(21). 4307–4307. 3 indexed citations
13.
Wallander, Michelle L., et al.. (2008). Iron-independent Phosphorylation of Iron Regulatory Protein 2 Regulates Ferritin during the Cell Cycle. Journal of Biological Chemistry. 283(35). 23589–23598. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026